Optomed launches Finland’s first automated software for screening of diabetic retinopathy

Diabetes is a global pandemic and diabetic retinopathy, which is a leading cause of vision loss among working age population. Optomed has come up with a new solution to reduce the risk of visual impairment.

As 30 % of all newly diagnosed diabetics already have symptoms of diabetic retinopathy. That’s why early screening is crucial for preventing vision loss.  Optomed Avenue is an easy-to-use, fast and accurate automatic screening service. It offers a cost-effective opportunity for better and preventive health care for both diabetics and those who have an elevated risk of diabetic retinopathy. Fundus image is analyzed with Optomed Avenue software to detect signs of diabetic retinopathy. The results are received in just a few seconds. The software enables referral to an ophthalmologist for further examination, if needed.

Optomed Avenue is available first in Finland in June and in selected markets later this year.

Contact person
Kristo Kivilaakso
Executive Vice President, Sales & Marketing
Tel: +358 40 554 5253
kristo.kivilaakso@optomed.com

← Back to news & blogs